PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

10 patients in a subjective assessment of pain reduction? Wake...

  1. 131 Posts.
    lightbulb Created with Sketch. 19
    10 patients in a subjective assessment of pain reduction? Wake up you guys! If you need more convincing take a look here: "Placebo-controlled clinical trials are the gold standard in drug development, in part to ensure that the efficacy of a new therapy exceeds the placebo response in the indication being studied. In osteoarthritis (OA), placebo treatment can result in pain reduction, functional improvement and stiffness reduction associated of up to 80% of the observed treatment efficacy. In fact, in randomized controlled trials, improvement perceived by OA patients taking placebo can be so great that some experts have suggested administration of placebo as a treatment option"

    https://www.tools4patient.com/the-placebo-response-in-drug-development-part-2-osteoarthritis/
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.